APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Insomnia Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Insomnia Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174003440327 December 2025196 pages

Choose your research edition.

Industry ResearchInsomnia Medication Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Insomnia Medication Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Insomnia Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insomnia Medication Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Insomnia Medication Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Insomnia Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Insomnia Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insomnia Medication include Takeda, Eisai, Sanofi, Johnson & Johnson, Merck, Pfizer, Vanda Pharmaceuticals, Somnus Therapeutics and SkyePharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insomnia Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insomnia Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insomnia Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insomnia Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Insomnia Medication Segment by Company

Takeda

Eisai

Sanofi

Johnson & Johnson

Merck

Pfizer

Vanda Pharmaceuticals

Somnus Therapeutics

SkyePharma

Purdue Pharma

Pernix Therapeutics

Paratek Pharmaceuticals

Neurim

Minerva Neurosciences

Meda

Flynn Pharma

ECR Pharmaceuticals (Valeant)

Dainippon Sumitomo

Astellas

Insomnia Medication Segment by Type

Benzodiazepine Receptor Agonists

Nonbenzodiazepine Receptor Agonists

The Selective Melatonin Receptor Agonist Ramelteon

Sedating Antidepressants

Insomnia Medication Segment by Application

Adults

Kids

Insomnia Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insomnia Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insomnia Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insomnia Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insomnia Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insomnia Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Insomnia Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Insomnia Medication Industry Trends Table 2. Insomnia Medication Industry Drivers Table 3. Insomnia Medication Industry Opportunities and Challenges Table 4. Insomnia Medication Industry Restraints Table 5. Global Insomnia Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Insomnia Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Insomnia Medication Sales by Manufacturers (W Pcs) & (2021-2026) Table 8. Global Insomnia Medication Sales Market Share by Manufacturers Table 9. Global Insomnia Medication Average Sales Price (US$/Pcs) of Manufacturers (2021-2026) Table 10. Global Insomnia Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Insomnia Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Insomnia Medication Manufacturers, Product Type & Application Table 13. Global Insomnia Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Insomnia Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Benzodiazepine Receptor Agonists Table 17. Major Manufacturers of Nonbenzodiazepine Receptor Agonists Table 18. Major Manufacturers of The Selective Melatonin Receptor Agonist Ramelteon Table 19. Major Manufacturers of Sedating Antidepressants Table 20. Global Insomnia Medication Sales by Type 2021 VS 2025 VS 2032 (W Pcs) Table 21. Global Insomnia Medication Sales by Type (2021-2026) & (W Pcs) Table 22. Global Insomnia Medication Sales by Type (2027-2032) & (W Pcs) Table 23. Global Insomnia Medication Sales Market Share by Type (2021-2026) Table 24. Global Insomnia Medication Sales Market Share by Type (2027-2032) Table 25. Global Insomnia Medication Revenue by Type 2021 VS 2025 VS 2032 (W Pcs) Table 26. Global Insomnia Medication Revenue by Type (2021-2026) & (W Pcs) Table 27. Global Insomnia Medication Revenue by Type (2027-2032) & (W Pcs) Table 28. Global Insomnia Medication Revenue Market Share by Type (2021-2026) Table 29. Global Insomnia Medication Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Adults Table 31. Major Manufacturers of Kids Table 32. Global Insomnia Medication Sales by Application 2021 VS 2025 VS 2032 (W Pcs) Table 33. Global Insomnia Medication Sales by Application (2021-2026) & (W Pcs) Table 34. Global Insomnia Medication Sales by Application (2027-2032) & (W Pcs) Table 35. Global Insomnia Medication Sales Market Share by Application (2021-2026) Table 36. Global Insomnia Medication Sales Market Share by Application (2027-2032) Table 37. Global Insomnia Medication Revenue by Application 2021 VS 2025 VS 2032 (W Pcs) Table 38. Global Insomnia Medication Revenue by Application (2021-2026) & (W Pcs) Table 39. Global Insomnia Medication Revenue by Application (2027-2032) & (W Pcs) Table 40. Global Insomnia Medication Revenue Market Share by Application (2021-2026) Table 41. Global Insomnia Medication Revenue Market Share by Application (2027-2032) Table 42. Global Insomnia Medication Sales by Region: 2021 VS 2025 VS 2032 (W Pcs) Table 43. Global Insomnia Medication Sales by Region (2021-2026) & (W Pcs) Table 44. Global Insomnia Medication Sales Market Share by Region (2021-2026) Table 45. Global Insomnia Medication Sales Forecasted by Region (2027-2032) & (W Pcs) Table 46. Global Insomnia Medication Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 48. North America Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 49. North America Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 50. Europe Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 51. Europe Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 52. Europe Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 53. Asia Pacific Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 54. Asia Pacific Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 55. Asia Pacific Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 56. South America, Middle East and Africa Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Pcs) Table 57. South America, Middle East and Africa Insomnia Medication Sales by Country (2021-2026) & (W Pcs) Table 58. South America, Middle East and Africa Insomnia Medication Sales by Country (2027-2032) & (W Pcs) Table 59. Global Insomnia Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Insomnia Medication Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Insomnia Medication Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Insomnia Medication Revenue Market Share by Region (2021-2026) Table 63. Global Insomnia Medication Revenue Market Share by Region (2027-2032) Table 64. Takeda Company Information Table 65. Takeda Business Overview Table 66. Takeda Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Takeda Insomnia Medication Product Portfolio Table 68. Takeda Recent Development Table 69. Eisai Company Information Table 70. Eisai Business Overview Table 71. Eisai Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Eisai Insomnia Medication Product Portfolio Table 73. Eisai Recent Development Table 74. Sanofi Company Information Table 75. Sanofi Business Overview Table 76. Sanofi Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Sanofi Insomnia Medication Product Portfolio Table 78. Sanofi Recent Development Table 79. Johnson & Johnson Company Information Table 80. Johnson & Johnson Business Overview Table 81. Johnson & Johnson Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Johnson & Johnson Insomnia Medication Product Portfolio Table 83. Johnson & Johnson Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Merck Insomnia Medication Product Portfolio Table 88. Merck Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Insomnia Medication Product Portfolio Table 93. Pfizer Recent Development Table 94. Vanda Pharmaceuticals Company Information Table 95. Vanda Pharmaceuticals Business Overview Table 96. Vanda Pharmaceuticals Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Vanda Pharmaceuticals Insomnia Medication Product Portfolio Table 98. Vanda Pharmaceuticals Recent Development Table 99. Somnus Therapeutics Company Information Table 100. Somnus Therapeutics Business Overview Table 101. Somnus Therapeutics Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Somnus Therapeutics Insomnia Medication Product Portfolio Table 103. Somnus Therapeutics Recent Development Table 104. SkyePharma Company Information Table 105. SkyePharma Business Overview Table 106. SkyePharma Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. SkyePharma Insomnia Medication Product Portfolio Table 108. SkyePharma Recent Development Table 109. Purdue Pharma Company Information Table 110. Purdue Pharma Business Overview Table 111. Purdue Pharma Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Purdue Pharma Insomnia Medication Product Portfolio Table 113. Purdue Pharma Recent Development Table 114. Pernix Therapeutics Company Information Table 115. Pernix Therapeutics Business Overview Table 116. Pernix Therapeutics Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 117. Pernix Therapeutics Insomnia Medication Product Portfolio Table 118. Pernix Therapeutics Recent Development Table 119. Paratek Pharmaceuticals Company Information Table 120. Paratek Pharmaceuticals Business Overview Table 121. Paratek Pharmaceuticals Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 122. Paratek Pharmaceuticals Insomnia Medication Product Portfolio Table 123. Paratek Pharmaceuticals Recent Development Table 124. Neurim Company Information Table 125. Neurim Business Overview Table 126. Neurim Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 127. Neurim Insomnia Medication Product Portfolio Table 128. Neurim Recent Development Table 129. Minerva Neurosciences Company Information Table 130. Minerva Neurosciences Business Overview Table 131. Minerva Neurosciences Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 132. Minerva Neurosciences Insomnia Medication Product Portfolio Table 133. Minerva Neurosciences Recent Development Table 134. Meda Company Information Table 135. Meda Business Overview Table 136. Meda Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 137. Meda Insomnia Medication Product Portfolio Table 138. Meda Recent Development Table 139. Flynn Pharma Company Information Table 140. Flynn Pharma Business Overview Table 141. Flynn Pharma Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 142. Flynn Pharma Insomnia Medication Product Portfolio Table 143. Flynn Pharma Recent Development Table 144. ECR Pharmaceuticals (Valeant) Company Information Table 145. ECR Pharmaceuticals (Valeant) Business Overview Table 146. ECR Pharmaceuticals (Valeant) Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 147. ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio Table 148. ECR Pharmaceuticals (Valeant) Recent Development Table 149. Dainippon Sumitomo Company Information Table 150. Dainippon Sumitomo Business Overview Table 151. Dainippon Sumitomo Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 152. Dainippon Sumitomo Insomnia Medication Product Portfolio Table 153. Dainippon Sumitomo Recent Development Table 154. Astellas Company Information Table 155. Astellas Business Overview Table 156. Astellas Insomnia Medication Sales (W Pcs), Price (US$/Pcs), Revenue (US$ Million) and Gross Margin (2021-2026) Table 157. Astellas Insomnia Medication Product Portfolio Table 158. Astellas Recent Development Table 159. Key Raw Materials Table 160. Raw Materials Key Suppliers Table 161. Insomnia Medication Distributors List Table 162. Insomnia Medication Customers List Table 163. Research Programs/Design for This Report Table 164. Authors List of This Report Table 165. Secondary Sources Table 166. Primary Sources List of Figures Figure 1. Insomnia Medication Product Image Figure 2. Global Insomnia Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insomnia Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Insomnia Medication Sales (2021-2032) & (W Pcs) Figure 5. Global Insomnia Medication Average Price (US$/Pcs) & (2021-2032) Figure 6. Global Top 5 and 10 Insomnia Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Benzodiazepine Receptor Agonists Image Figure 9. Nonbenzodiazepine Receptor Agonists Image Figure 10. The Selective Melatonin Receptor Agonist Ramelteon Image Figure 11. Sedating Antidepressants Image Figure 12. Global Insomnia Medication Sales by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 13. Global Insomnia Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Insomnia Medication Sales Market Share by Type (2021-2032) Figure 15. Global Insomnia Medication Revenue by Type (2021 VS 2025 VS 2032) & (W Pcs) Figure 16. Global Insomnia Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Insomnia Medication Revenue Market Share by Type (2021-2032) Figure 18. Adults Image Figure 19. Kids Image Figure 20. Global Insomnia Medication Sales by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 21. Global Insomnia Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Insomnia Medication Sales Market Share by Application (2021-2032) Figure 23. Global Insomnia Medication Revenue by Application (2021 VS 2025 VS 2032) & (W Pcs) Figure 24. Global Insomnia Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Insomnia Medication Revenue Market Share by Application (2021-2032) Figure 26. North America Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 27. North America Insomnia Medication Sales Market Share by Country (2021-2032) Figure 28. U.S. Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 29. Canada Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 30. Mexico Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 31. Europe Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 32. Europe Insomnia Medication Sales Market Share by Country (2021-2032) Figure 33. Germany Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 34. France Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 35. U.K. Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 36. Italy Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 37. Netherlands Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 38. Asia Pacific Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 39. Asia Pacific Insomnia Medication Sales Market Share by Country (2021-2032) Figure 40. China Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 41. Japan Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 42. South Korea Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 43. Southeast Asia Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 44. India Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 45. Australia Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 46. South America, Middle East and Africa Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 47. South America, Middle East and Africa Insomnia Medication Sales Market Share by Country (2021-2032) Figure 48. Brazil Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 49. South Africa Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 50. Saudi Arabia Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 51. Turkey Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 52. Argentina Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 53. UAE Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 54. Egypt Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 55. Chile Insomnia Medication Sales and Growth Rate (2021-2032) & (W Pcs) Figure 56. Global Insomnia Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Insomnia Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Insomnia Medication Revenue (2021-2032) & (US$ Million) Figure 59. North America Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Insomnia Medication Revenue (2021-2032) & (US$ Million) Figure 61. Europe Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Insomnia Medication Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Insomnia Medication Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Insomnia Medication Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Insomnia Medication Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Benzodiazepine Receptor Agonists
  • Nonbenzodiazepine Receptor Agonists
  • The Selective Melatonin Receptor Agonist Ramelteon
  • Sedating Antidepressants
Applications
  • Adults
  • Kids
Companies covered
  • Takeda
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • Merck
  • Pfizer
  • Vanda Pharmaceuticals
  • Somnus Therapeutics
  • SkyePharma
  • Purdue Pharma
  • Pernix Therapeutics
  • Paratek Pharmaceuticals
  • Neurim
  • Minerva Neurosciences
  • Meda
  • Flynn Pharma
  • ECR Pharmaceuticals (Valeant)
  • Dainippon Sumitomo
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Insomnia Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Insomnia Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Insomnia Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Insomnia Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Insomnia Medication Market Dynamics
  1. 2.1 Insomnia Medication Industry Trends
  2. 2.2 Insomnia Medication Industry Drivers
  3. 2.3 Insomnia Medication Industry Opportunities and Challenges
  4. 2.4 Insomnia Medication Industry Restraints
3 Insomnia Medication Market by Manufacturers
  1. 3.1 Global Insomnia Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Insomnia Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Insomnia Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Insomnia Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insomnia Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Insomnia Medication Manufacturers, Product Type & Application
  7. 3.7 Global Insomnia Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insomnia Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insomnia Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insomnia Medication Tier 1, Tier 2, and Tier 3
4 Insomnia Medication Market by Type
  1. 4.1 Insomnia Medication Type Introduction
  2. 4.1.1 Benzodiazepine Receptor Agonists
  3. 4.1.2 Nonbenzodiazepine Receptor Agonists
  4. 4.1.3 The Selective Melatonin Receptor Agonist Ramelteon
  5. 4.1.4 Sedating Antidepressants
  6. 4.2 Global Insomnia Medication Sales by Type
  7. 4.2.1 Global Insomnia Medication Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Insomnia Medication Sales by Type (2021-2032)
  9. 4.2.3 Global Insomnia Medication Sales Market Share by Type (2021-2032)
  10. 4.3 Global Insomnia Medication Revenue by Type
  11. 4.3.1 Global Insomnia Medication Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Insomnia Medication Revenue by Type (2021-2032)
  13. 4.3.3 Global Insomnia Medication Revenue Market Share by Type (2021-2032)
5 Insomnia Medication Market by Application
  1. 5.1 Insomnia Medication Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Kids
  4. 5.2 Global Insomnia Medication Sales by Application
  5. 5.2.1 Global Insomnia Medication Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Insomnia Medication Sales by Application (2021-2032)
  7. 5.2.3 Global Insomnia Medication Sales Market Share by Application (2021-2032)
  8. 5.3 Global Insomnia Medication Revenue by Application
  9. 5.3.1 Global Insomnia Medication Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Insomnia Medication Revenue by Application (2021-2032)
  11. 5.3.3 Global Insomnia Medication Revenue Market Share by Application (2021-2032)
6 Global Insomnia Medication Sales by Region
  1. 6.1 Global Insomnia Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insomnia Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Insomnia Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Insomnia Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Insomnia Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Insomnia Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Insomnia Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Insomnia Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Insomnia Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Insomnia Medication Revenue by Region
  1. 7.1 Global Insomnia Medication Revenue by Region
  2. 7.1.1 Global Insomnia Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Insomnia Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Insomnia Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Insomnia Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Insomnia Medication Revenue (2021-2032)
  8. 7.2.2 North America Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Insomnia Medication Revenue (2021-2032)
  11. 7.3.2 Europe Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Insomnia Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Insomnia Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Insomnia Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Takeda
  2. 8.1.1 Takeda Company Information
  3. 8.1.2 Takeda Business Overview
  4. 8.1.3 Takeda Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Takeda Insomnia Medication Product Portfolio
  6. 8.1.5 Takeda Recent Developments
  7. 8.2 Eisai
  8. 8.2.1 Eisai Company Information
  9. 8.2.2 Eisai Business Overview
  10. 8.2.3 Eisai Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eisai Insomnia Medication Product Portfolio
  12. 8.2.5 Eisai Recent Developments
  13. 8.3 Sanofi
  14. 8.3.1 Sanofi Company Information
  15. 8.3.2 Sanofi Business Overview
  16. 8.3.3 Sanofi Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sanofi Insomnia Medication Product Portfolio
  18. 8.3.5 Sanofi Recent Developments
  19. 8.4 Johnson & Johnson
  20. 8.4.1 Johnson & Johnson Company Information
  21. 8.4.2 Johnson & Johnson Business Overview
  22. 8.4.3 Johnson & Johnson Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Johnson & Johnson Insomnia Medication Product Portfolio
  24. 8.4.5 Johnson & Johnson Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Insomnia Medication Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Insomnia Medication Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Vanda Pharmaceuticals
  38. 8.7.1 Vanda Pharmaceuticals Company Information
  39. 8.7.2 Vanda Pharmaceuticals Business Overview
  40. 8.7.3 Vanda Pharmaceuticals Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vanda Pharmaceuticals Insomnia Medication Product Portfolio
  42. 8.7.5 Vanda Pharmaceuticals Recent Developments
  43. 8.8 Somnus Therapeutics
  44. 8.8.1 Somnus Therapeutics Company Information
  45. 8.8.2 Somnus Therapeutics Business Overview
  46. 8.8.3 Somnus Therapeutics Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Somnus Therapeutics Insomnia Medication Product Portfolio
  48. 8.8.5 Somnus Therapeutics Recent Developments
  49. 8.9 SkyePharma
  50. 8.9.1 SkyePharma Company Information
  51. 8.9.2 SkyePharma Business Overview
  52. 8.9.3 SkyePharma Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 SkyePharma Insomnia Medication Product Portfolio
  54. 8.9.5 SkyePharma Recent Developments
  55. 8.10 Purdue Pharma
  56. 8.10.1 Purdue Pharma Company Information
  57. 8.10.2 Purdue Pharma Business Overview
  58. 8.10.3 Purdue Pharma Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Purdue Pharma Insomnia Medication Product Portfolio
  60. 8.10.5 Purdue Pharma Recent Developments
  61. 8.11 Pernix Therapeutics
  62. 8.11.1 Pernix Therapeutics Company Information
  63. 8.11.2 Pernix Therapeutics Business Overview
  64. 8.11.3 Pernix Therapeutics Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pernix Therapeutics Insomnia Medication Product Portfolio
  66. 8.11.5 Pernix Therapeutics Recent Developments
  67. 8.12 Paratek Pharmaceuticals
  68. 8.12.1 Paratek Pharmaceuticals Company Information
  69. 8.12.2 Paratek Pharmaceuticals Business Overview
  70. 8.12.3 Paratek Pharmaceuticals Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Paratek Pharmaceuticals Insomnia Medication Product Portfolio
  72. 8.12.5 Paratek Pharmaceuticals Recent Developments
  73. 8.13 Neurim
  74. 8.13.1 Neurim Company Information
  75. 8.13.2 Neurim Business Overview
  76. 8.13.3 Neurim Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Neurim Insomnia Medication Product Portfolio
  78. 8.13.5 Neurim Recent Developments
  79. 8.14 Minerva Neurosciences
  80. 8.14.1 Minerva Neurosciences Company Information
  81. 8.14.2 Minerva Neurosciences Business Overview
  82. 8.14.3 Minerva Neurosciences Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Minerva Neurosciences Insomnia Medication Product Portfolio
  84. 8.14.5 Minerva Neurosciences Recent Developments
  85. 8.15 Meda
  86. 8.15.1 Meda Company Information
  87. 8.15.2 Meda Business Overview
  88. 8.15.3 Meda Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Meda Insomnia Medication Product Portfolio
  90. 8.15.5 Meda Recent Developments
  91. 8.16 Flynn Pharma
  92. 8.16.1 Flynn Pharma Company Information
  93. 8.16.2 Flynn Pharma Business Overview
  94. 8.16.3 Flynn Pharma Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Flynn Pharma Insomnia Medication Product Portfolio
  96. 8.16.5 Flynn Pharma Recent Developments
  97. 8.17 ECR Pharmaceuticals (Valeant)
  98. 8.17.1 ECR Pharmaceuticals (Valeant) Company Information
  99. 8.17.2 ECR Pharmaceuticals (Valeant) Business Overview
  100. 8.17.3 ECR Pharmaceuticals (Valeant) Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 ECR Pharmaceuticals (Valeant) Insomnia Medication Product Portfolio
  102. 8.17.5 ECR Pharmaceuticals (Valeant) Recent Developments
  103. 8.18 Dainippon Sumitomo
  104. 8.18.1 Dainippon Sumitomo Company Information
  105. 8.18.2 Dainippon Sumitomo Business Overview
  106. 8.18.3 Dainippon Sumitomo Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Dainippon Sumitomo Insomnia Medication Product Portfolio
  108. 8.18.5 Dainippon Sumitomo Recent Developments
  109. 8.19 Astellas
  110. 8.19.1 Astellas Company Information
  111. 8.19.2 Astellas Business Overview
  112. 8.19.3 Astellas Insomnia Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Astellas Insomnia Medication Product Portfolio
  114. 8.19.5 Astellas Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insomnia Medication Value Chain Analysis
  2. 9.1.1 Insomnia Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insomnia Medication Production Mode & Process
  6. 9.2 Insomnia Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insomnia Medication Distributors
  9. 9.2.3 Insomnia Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst